Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

68Ga-NK224 PET Imaging of PD-L1 Expression in Cancers

NCT06754345 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Xiamen University as lead sponsor.

NCT NCT06754345
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06754345 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
68Ga-NK224 PET Imaging of PD-L1 Expression in Cancers
Lead sponsor
The First Affiliated Hospital of Xiamen University
Phase
Observational
Overall status
Recruiting
Start date
May 30, 2023
Completion date
November 30, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pd-l1, tumor